Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

ELEVANCE HEALTH, INC.

Filed by MEHLMAN CONSULTING, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
$90,000.00
Expenses
Not reported
Filing UUID
49a1df4e-e4d4-4b4a-a9d8-0c7220dccde1
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. H.R. 1/PL 119-21 - One Big Beautiful Bill Act.

Literal federal measure citations: H.R. 1

MMM · Medicare/Medicaid

Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. S. 1105 - No UPCODE Act. H.R. 1/PL 119-21 - One Big Beautiful Bill Act.

Literal federal measure citations: S. 1105, H.R. 1

PHA · Pharmacy

Prescription Drug Pricing.

TAX · Taxation/Internal Revenue Code

Issues related to advanced premium tax credits. H.R. 1/PL 119-21 - One Big Beautiful Bill Act.

Literal federal measure citations: H.R. 1

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.